LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
68 hedge funds and large institutions have $16.3M invested in Lumos Pharma, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
76% less call options, than puts
Call options by funds: $294K | Put options by funds: $1.22M
Holders
68
Holding in Top 10
–
Calls
$294K
Puts
$1.22M
Top Buyers
| 1 | +$434K | |
| 2 | +$373K | |
| 3 | +$190K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$142K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$89K |
Top Sellers
| 1 | -$372K | |
| 2 | -$306K | |
| 3 | -$295K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$287K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$211K |